Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Adamas Pharmaceuticals Inc (ADMS)
Adamas Pharmaceuticals Inc (ADMS) News

ADMS

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADMS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2024	12:21PM	iHub Newswire	FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
01/02/2019	9:14AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
12/28/2018	4:28PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
12/26/2018	5:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
12/21/2018	4:49PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
12/18/2018	4:30PM	GlobeNewswire Inc.	Adamas Announces Issuance of New U.S. Patent Covering GOCOVRI™	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
11/28/2018	7:30AM	InvestorsHub NewsWire	Coeptis Pharma Enters into Agreement to Acquire Elto Pharma	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
11/09/2018	1:49PM	GlobeNewswire Inc.	Adamas to Present at Three November Investor Conferences	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
11/01/2018	4:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
11/01/2018	4:05PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
11/01/2018	4:01PM	GlobeNewswire Inc.	Adamas Reports Third Quarter 2018 Financial Results	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
10/26/2018	9:00AM	GlobeNewswire Inc.	Adamas to Announce Third Quarter 2018 Financial Results and Host Conference Call on November 1, 2018	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
10/10/2018	10:06AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
10/08/2018	8:30AM	GlobeNewswire Inc.	Adamas Presents Final Results from the Two-Year, Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients wit...	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
10/05/2018	5:51PM	GlobeNewswire Inc.	Adamas Announces New Employment Inducement Grant	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
10/04/2018	4:11PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
10/04/2018	9:00AM	GlobeNewswire Inc.	Adamas Announces Publication of Data Demonstrating Dyskinesia’s Impact on Activities of Daily Living in People with Parkins...	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
09/24/2018	8:50AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
09/21/2018	7:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
09/14/2018	4:22PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
09/12/2018	4:30PM	GlobeNewswire Inc.	Adamas Announces New Employment Inducement Grant	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
08/08/2018	4:30PM	GlobeNewswire Inc.	Adamas Announces New Employment Inducement Grant	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
08/02/2018	4:44PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
08/02/2018	4:44PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
08/02/2018	4:01PM	GlobeNewswire Inc.	Adamas Reports Second Quarter 2018 Financial Results	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
08/01/2018	9:00AM	GlobeNewswire Inc.	Adamas Pharmaceuticals Launches “Dyskinesia Is A Jerk™,” a Campaign to Raise Awareness and Highlight the Impact of Park...	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
07/26/2018	12:05PM	GlobeNewswire Inc.	Adamas to Announce Second Quarter 2018 Financial Results and Host Conference Call on August 2, 2018	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
07/23/2018	6:15AM	PR Newswire (US)	Pre-Market Research Reports on Generic Drugs Stocks -- Tricida, Zoetis, Adamas Pharma, and Allergan	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
07/09/2018	4:39PM	GlobeNewswire Inc.	Adamas Announces New Employment Inducement Grant	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
06/22/2018	4:51PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc